- Home
- NOG vs DYN Comparison
NOG vs DYN Comparison
Compare NOG & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NOG | DYN |
|---|---|---|
| Founded | 2006 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NOG | DYN |
|---|---|---|
| Price | $28.07 | $17.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 14 |
| Target Price | $31.14 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 2.2M | 1.7M |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | ★ 6.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $2,475,723,000.00 | N/A |
| Revenue This Year | $14.07 | N/A |
| Revenue Next Year | $4.24 | N/A |
| P/E Ratio | $70.64 | ★ N/A |
| Revenue Growth | ★ 11.23 | N/A |
| 52 Week Low | $20.18 | $8.25 |
| 52 Week High | $32.62 | $25.00 |
Technical Indicators
Market Signals| Indicator | NOG | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 56.28 | 41.96 |
| Support Level | $26.65 | $16.47 |
| Resistance Level | $28.22 | $19.65 |
| Average True Range (ATR) | 0.88 | 1.05 |
| MACD | 0.18 | -0.28 |
| Stochastic Oscillator | 86.70 | 3.43 |
Price Performance
Historical ComparisonAbout NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.